Please tell us a little bit about yourself so we can better assist you.
Thank you. We will be in contact with you shortly.
PIK3CA was previously not covered. The FDA approved a new drug for breast cancer that requires PIK3CA testing. This change is effective 5/24/19.
Thank you for subscribing. View XIFIN Blog.
Thank you.You are now subscribed to receive XIFIN's monthly billing newsletter. In the meantime, please check your inbox for a copy of our most recent newsletter.
© 2019 XIFIN, Inc. All Rights Reserved.